Zhang, Chan. 2020. “Connecting Asciminib Tolerability to Long-Term Treatment Persistence. Comment On: "Favorable Tolerability of Asciminib Versus ATP-Competitive Tyrosine Kinase Inhibitors in the ASC4FIRST Study of Newly Diagnosed Patients With Chronic-Phase Chronic Myeloid leukemia"”. Haematologica, September. Pavia, Italy. https://doi.org/10.3324/haematol.2026.301608.